Rucaparib efficacious in metastatic castration-resistant prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer, treatment with rucaparib is associated with significantly longer duration of imaging-based progression-free survival

Updated on: December 28,2023 10

Rucaparib efficacious in metastatic castration-resistant prostate cancer

by Elana GotkineFor patients with metastatic castration-resistant prostate cancer, treatment with rucaparib is associated with significantly longer duration of imaging-based progression-free survival

Updated on:December 28,2023 10

New genetic culprit suspected in the onset of pancreatic cancer

by Virginia Commonwealth UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111623New research out of VCU Massey Cancer Center points to the inactivat

Updated on: January 30,2024 17

New genetic culprit suspected in the onset of pancreatic cancer

by Virginia Commonwealth UniversityGraphical abstract. Credit:Cell Reports(2022). DOI: 10.1016/j.celrep.2022.111623New research out of VCU Massey Cancer Center points to the inactivat

Updated on:January 30,2024 17

Inside the new colorectal cancer screening guidelines for average-risk patients

by Mayo Clinic News NetworkCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0The American College of Physicians has produced a guidance statement for colorectal cancer s

Updated on: April 20,2024 15

Inside the new colorectal cancer screening guidelines for average-risk patients

by Mayo Clinic News NetworkCancer—Histopathologic image of colonic carcinoid. Credit: Wikipedia/CC BY-SA 3.0The American College of Physicians has produced a guidance statement for colorectal cancer s

Updated on:April 20,2024 15

Researchers design multiclass cancer diagnostic tool using AI and miRNA

by Florida Atlantic UniversityCancers originating from different primary sample sites have specific patterns of miRNA expression, as revealed by principal component analysis, a popular technique

Updated on: January 28,2024 14

Researchers design multiclass cancer diagnostic tool using AI and miRNA

by Florida Atlantic UniversityCancers originating from different primary sample sites have specific patterns of miRNA expression, as revealed by principal component analysis, a popular technique

Updated on:January 28,2024 14

Curbing blood cancers by teaching immune cells to kill mutant stem cells

by Nancy Fliesler,Children's Hospital BostonROS and TLR3 signaling mediates the "eat-me" and "don't eat me" signals that determine stem cell clonal selection by macro

Updated on: October 24,2024 0

Curbing blood cancers by teaching immune cells to kill mutant stem cells

by Nancy Fliesler,Children's Hospital BostonROS and TLR3 signaling mediates the "eat-me" and "don't eat me" signals that determine stem cell clonal selection by macro

Updated on:October 24,2024 0

Prolonging the survival of patients with gastric cancer

by Anne Grimm,Leipzig UniversityCredit: Unsplash/CC0 Public DomainGastric cancer is the fifth most commonly diagnosed malignancy worldwide. It ranks a sad third in cancer-related causes of death

Updated on: January 16,2024 16

Prolonging the survival of patients with gastric cancer

by Anne Grimm,Leipzig UniversityCredit: Unsplash/CC0 Public DomainGastric cancer is the fifth most commonly diagnosed malignancy worldwide. It ranks a sad third in cancer-related causes of death

Updated on:January 16,2024 16

Small device for earlier ovarian cancer detection

by Emily Dieckman,University of ArizonaJennifer Barton, director of the University of Arizona BIO5 Institute and Thomas R. Brown Distinguished Chair in Biomedical Engineering, has spent years de

Updated on: May 05,2024 15

Small device for earlier ovarian cancer detection

by Emily Dieckman,University of ArizonaJennifer Barton, director of the University of Arizona BIO5 Institute and Thomas R. Brown Distinguished Chair in Biomedical Engineering, has spent years de

Updated on:May 05,2024 15

CAR-T Therapy Under Scrutiny: The Emerging Risk of Secondary Malignant Tumors

CAR-T therapy has long been an effective treatment for hematological cancers such as leukemia and lymphoma. However, some patients have developed secondary malignant tumors after undergoing CAR-T ......

Updated on: May 29,2024 0

CAR-T Therapy Under Scrutiny: The Emerging Risk of Secondary Malignant Tumors

CAR-T therapy has long been an effective treatment for hematological cancers such as leukemia and lymphoma. However, some patients have developed secondary malignant tumors after undergoing CAR-T ......

Updated on:May 29,2024 0

p53 mutations in 10,000 cancer patients shed new light on gene's function

by Molly Chiu,Baylor College of MedicineKiller T cells surround a cancer cell. Credit: NIHOne of the most extensively studied genes in cancer, TP53 is well known for its role as a tumor suppress

Updated on: March 14,2024 15

p53 mutations in 10,000 cancer patients shed new light on gene's function

by Molly Chiu,Baylor College of MedicineKiller T cells surround a cancer cell. Credit: NIHOne of the most extensively studied genes in cancer, TP53 is well known for its role as a tumor suppress

Updated on:March 14,2024 15

Exploring novel mechanisms and therapeutic targets for acute myeloid leukemia

by Melissa Rohman,Northwestern UniversityAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainPatients with acute myeloid leukemia, the most common type of adult blood cancer, show

Updated on: January 07,2024 41

Exploring novel mechanisms and therapeutic targets for acute myeloid leukemia

by Melissa Rohman,Northwestern UniversityAcute myelocytic leukemia (AML). Credit: Unsplash/CC0 Public DomainPatients with acute myeloid leukemia, the most common type of adult blood cancer, show

Updated on:January 07,2024 41

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on: January 04,2024 10

Trial finds adding immune modulator to targeted therapy does not improve survival in difficult-to-treat thyroid cancer

byUniversity of Chicago Medical CenterCredit: Pixabay/CC0 Public DomainResults of a multicenter phase II clinical trial led by the University of Chicago Medicine Comprehensive Cancer Center show

Updated on:January 04,2024 10

Largest-ever genetic study of prostate cancer in men of African descent finds new risk factors for the disease

by Keck School of Medicine of USCCredit: Unsplash/CC0 Public DomainProstate cancer takes a greater toll on Black men than on men of other races. In the United States, one in six Black men will ge

Updated on: January 30,2024 14

Largest-ever genetic study of prostate cancer in men of African descent finds new risk factors for the disease

by Keck School of Medicine of USCCredit: Unsplash/CC0 Public DomainProstate cancer takes a greater toll on Black men than on men of other races. In the United States, one in six Black men will ge

Updated on:January 30,2024 14